- Products
- Reproduction
- Molecular diagnostics
- Careers
- About us
- Contacts
eazyplex® CSF direct is a ready-to-use, lyophilized in vitro diagnostic assay that detects both bacterial and viral pathogens from CSF. The panel includes targets frequently associated with meningitis and other serious central nervous system infections, making it a valuable tool for rapid diagnostic support in urgent clinical settings.
Utilizes LAMP (Loop-Mediated Isothermal Amplification) technology for fast and specific detection directly from cerebrospinal fluid.
No DNA extraction step is needed, reducing hands-on time and complexity.
Results are available in approximately 30 minutes, enabling timely clinical decisions.
Real-time amplification detection allows early identification of pathogens.
The standard eazyplex® CSF direct kit includes detection of these common CNS infection agents:
HSV-1 (Herpes Simplex Virus Type 1)
HSV-2 (Herpes Simplex Virus Type 2)
VZV (Varicella-Zoster Virus)
Neisseria meningitidis
Streptococcus pneumoniae
Streptococcus agalactiae
Listeria monocytogenes
Variant panels are also available:
eazyplex® CSF direct M – bacterial panel including additional H. influenzae and E. coli parameters.
eazyplex® CSF direct V – viral panel focused on HSV-1, HSV-2, and VZV.
Rapid turnaround time (~30 min) supports early therapeutic decisions.
Simplified workflow with no DNA extraction reduces preparation time.
Lyophilized reagents are stable and ready to use.
Detects both bacterial and viral CNS pathogens in one panel.
This test is intended for clinical microbiology laboratories as an aid in the rapid identification of pathogens in cerebrospinal fluid from patients with suspected meningitis or central nervous system infections. Quick pathogen detection supports prompt treatment initiation and improved patient management.
For more information, please contact us by e-mail: diagnostika@pentagen.cz